MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.25 USD | +0.47% |
|
-2.82% | +5.71% |
| 12/09 | Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors | MT |
| 11/09 | Merck: positive results for HPV vaccine | CF |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 26 | |||||||||
| 25 | |||||||||
| 26 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 19 | |||||||||
| 20 | |||||||||
| 20 | |||||||||
| 24 | |||||||||
| 22 | |||||||||
| 22 | |||||||||
| 27 | |||||||||
| 21 | |||||||||
| 21 | |||||||||
| 15 | |||||||||
| 16 | |||||||||
| 18 | |||||||||
| 17 | |||||||||
| 15 | |||||||||
| Average | 21 | ||||||||
| Weighted average by Cap. | 23 |
- Stock Market
- Equities
- MRK Stock
- Sector Merck & Co., Inc.
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition